These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5671518)

  • 1. [Rules for the advertising of special preparations? Suggestion for a safe standardization].
    Naess K
    Tidsskr Nor Laegeforen; 1968 Mar; 88(5):347-9. PubMed ID: 5671518
    [No Abstract]   [Full Text] [Related]  

  • 2. A defense of the learned intermediary doctrine.
    Goetz RB; Growdon KR
    Food Drug Law J; 2008; 63(2):421-38. PubMed ID: 18561470
    [No Abstract]   [Full Text] [Related]  

  • 3. Dealing with drug advertising. The FDA can't always enforce the rules on misleading ads.
    Atkinson HG
    Health News; 2003 Feb; 9(2):5. PubMed ID: 12632541
    [No Abstract]   [Full Text] [Related]  

  • 4. Plugs for drugs.
    Masson A; Rubin PH
    Regulation; 1986; 10(1):37-43, 53. PubMed ID: 10280556
    [No Abstract]   [Full Text] [Related]  

  • 5. The Food and Drug Administration's regulation of drug labeling, advertising, and promotion: looking back and looking ahead.
    Hayes TA
    Clin Pharmacol Ther; 1998 Jun; 63(6):607-16. PubMed ID: 9663174
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent developments in pharmaceutical products liability law: failure to warn, the learned intermediary defense, and other issues in the new millennium.
    Garbutt BJ; Hofmann ME
    Food Drug Law J; 2003; 58(2):269-86. PubMed ID: 12866558
    [No Abstract]   [Full Text] [Related]  

  • 7. The patient package insert and its legal implications.
    Cook D
    Leg Med Q; 1980; 4():258-70. PubMed ID: 10258797
    [No Abstract]   [Full Text] [Related]  

  • 8. The economic wisdom of regulating pharmaceutical "freebies".
    Fisher SH
    Duke Law J; 1991 Feb; (1):206-39. PubMed ID: 10114416
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ethics of medical advertising].
    de Oliveira E
    Hospital (Rio J); 1969 Oct; 76(4):1385-94. PubMed ID: 5308117
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug labeling and promotion: evolution and application of regulatory policy.
    Hayes TA
    Food Drug Law J; 1996; 51(1):57-73. PubMed ID: 11794353
    [No Abstract]   [Full Text] [Related]  

  • 11. The pharmacist and the FTC: Part I.
    Simonsmeier LM
    Pharm Manage Comb Am J Pharm; 1979; 151(2):68-9. PubMed ID: 441148
    [No Abstract]   [Full Text] [Related]  

  • 12. Safe & sound. Interview by Helena Gail Rubinstein.
    Woodcock J
    AHIP Cover; 2009; 50(2):38-43. PubMed ID: 19385317
    [No Abstract]   [Full Text] [Related]  

  • 13. Patient labeling regulations.
    Pruitt NL
    Med Mark Media; 1980 Jul; 15(7):2, 6, 8. PubMed ID: 10247689
    [No Abstract]   [Full Text] [Related]  

  • 14. Enterprise liability for bad outcomes from drug therapy: the doctor, the hospital, the pharmacy, and the drug firm.
    Furrow BR
    Spec Law Dig Health Care Law; 1998 Apr; (229):9-69. PubMed ID: 10178162
    [No Abstract]   [Full Text] [Related]  

  • 15. Must labels name the drug?
    Gursky S
    J Leg Med (N Y); 1977 Mar; 5(3):17-9. PubMed ID: 300420
    [No Abstract]   [Full Text] [Related]  

  • 16. Institute of Medicine's new drug safety report: implications for Canada.
    Cassels A
    CMAJ; 2006 Dec; 175(12):1515-6. PubMed ID: 17146086
    [No Abstract]   [Full Text] [Related]  

  • 17. Prescription for trouble: common drugs, hidden dangers. Tens of people are at risk.
    Consum Rep; 2006 Jan; 71(1):34-9. PubMed ID: 16491527
    [No Abstract]   [Full Text] [Related]  

  • 18. Stoning a dead bird: advertising limits on approved new drugs.
    Strobos J
    Food Drug Law J; 1995; 50(4):533-51. PubMed ID: 10343018
    [No Abstract]   [Full Text] [Related]  

  • 19. Prescription drug advertising--should states regulate what is false and misleading?
    Shaeffer J
    Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454
    [No Abstract]   [Full Text] [Related]  

  • 20. The patient medication instruction (PMI) leaflet: regulatory and evidentiary ramifications.
    Yacura M
    Spec Law Dig Health Care (Mon); 1986 Mar; 8(1):7-27. PubMed ID: 10276993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.